146 related articles for article (PubMed ID: 10096838)
1. The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatography.
Tata PN; Fu CH; Browder NJ; Chow PC; Bramer SL
J Pharm Biomed Anal; 1998 Nov; 18(3):441-51. PubMed ID: 10096838
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatography.
Fu CJ; Tata PN; Okada K; Akiyama H; Bramer SL
J Chromatogr B Biomed Sci Appl; 1999 May; 728(2):251-62. PubMed ID: 10406210
[TBL] [Abstract][Full Text] [Related]
3. Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography.
Tata PN; Fu CH; Bramer SL
J Pharm Biomed Anal; 2001 Jan; 24(3):381-9. PubMed ID: 11199217
[TBL] [Abstract][Full Text] [Related]
4. Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MS.
Bramer SL; Tata PN; Vengurlekar SS; Brisson JH
J Pharm Biomed Anal; 2001 Nov; 26(4):637-50. PubMed ID: 11516916
[TBL] [Abstract][Full Text] [Related]
5. A validated stability indicating high performance reverse phase liquid chromatographic method for the determination of cilostazol in bulk drug substance.
Jadhav AS; Pathare DB; Shingare MS
Drug Dev Ind Pharm; 2007 Feb; 33(2):173-9. PubMed ID: 17454049
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.
Shah VR; Srinivas NR; Campbell DA; Mantha S; Duncan G; Schuster A; Whigan DW; Shyu WC
Biomed Chromatogr; 1996; 10(3):135-8. PubMed ID: 8792865
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms.
Abbas R; Chow CP; Browder NJ; Thacker D; Bramer SL; Fu CJ; Forbes W; Odomi M; Flockhart DA
Hum Exp Toxicol; 2000 Mar; 19(3):178-84. PubMed ID: 10889516
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography - tandem mass spectrometry for the simultaneous quantitation of glipizide, cilostazol and its active metabolite 3, 4-dehydro-cilostazol in rat plasma: application for a pharmacokinetic study.
Satheeshmanikandan TR; Sridhar V; Kanthikiran VV; Swaroopkumar VV; Mukkanti K
Arzneimittelforschung; 2012 Sep; 62(9):425-32. PubMed ID: 22821721
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry.
Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Shrivasthava W; Datla PV; Yerramilli A
Anal Bioanal Chem; 2006 Feb; 384(3):780-90. PubMed ID: 16440196
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes.
Katsuki H; Hamada A; Nakamura C; Arimori K; Nakano M
J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(1):127-33. PubMed ID: 11419737
[TBL] [Abstract][Full Text] [Related]
11. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-mass spectrometry assay for quantitation of ifosfamide and its N-deschloroethylated metabolites in rat microsomal medium.
Storme T; Mercier L; Deroussent A; Re M; Martens T; Royer J; Bourget P; Vassal G; Paci A
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(2):251-9. PubMed ID: 15899378
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of transdermal tadalafil in human skin by reversed-phase high-performance liquid chromatography.
Mehanna MM; Motawaa AM; Samaha MW
J AOAC Int; 2012; 95(4):1064-8. PubMed ID: 22970573
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study.
Varanasi KK; Sridhar V; Potharaju S; Shraddha R; Sivakumar SP; Sabapathi SK; Satheeshmanikandan TR; Kumar VV
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):91-8. PubMed ID: 18342586
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
Oh KS; Park SJ; Shinde DD; Shin JG; Kim DH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():56-64. PubMed ID: 22483397
[TBL] [Abstract][Full Text] [Related]
16. Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation.
Roupe K; Teng XW; Fu X; Meadows GG; Davies NM
Biomed Chromatogr; 2004 Oct; 18(8):486-91. PubMed ID: 15386525
[TBL] [Abstract][Full Text] [Related]
17. Validated high performance liquid chromatographic method for simultaneous determination of rosiglitazone, cilostazol, and 3,4-dehydro-cilostazol in rat plasma and its application to pharmacokinetics.
Varanasi VS; Veeraraghavan S; Potharaju S; Thappali RS; Raghavan R; Vakkalanka VS
Arzneimittelforschung; 2008; 58(6):288-96. PubMed ID: 18677971
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study.
Sala F; Marangon E; Bagnati R; Livi V; Cereda R; D'Incalci M; Zucchetti M
J Mass Spectrom; 2010 Nov; 45(11):1299-305. PubMed ID: 20872901
[TBL] [Abstract][Full Text] [Related]
19. Quality evaluation of golden saxifrage (Chrysosplenium alternifolium L.) through simultaneous determination of four bioactive flavonoids by high-performance liquid chromatography with PDA detection.
Olszewska MA; Gudej J
J Pharm Biomed Anal; 2009 Dec; 50(5):771-7. PubMed ID: 19615839
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography.
Xu X; Fu Y; Hu H; Duan Y; Zhang Z
J Pharm Biomed Anal; 2006 Apr; 41(1):266-73. PubMed ID: 16303273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
